生物膜
伤口愈合
化学
活性氧
黑色素
细菌
光热治疗
自愈水凝胶
微生物学
细胞生物学
炎症
抗菌活性
模式生物
抗氧化剂
生物物理学
脚手架
慢性伤口
代谢活性
氧化应激
调解人
体内
苏云金杆菌
分泌物
纳米技术
作者
Wendi Xuan,Yongbiao Hu,Sicong Li,Xiaozhen Zhou,Meng Chen,Chenyao Wu,Xiang Gao,Gaoyan Xu,Jun Zhao,Lili Xia,Wei Feng,Yu Chen
标识
DOI:10.1002/adhm.202503107
摘要
Diabetic wound healing remains a formidable clinical challenge due to persistent biofilm formation, chronic inflammation, and excessive reactive oxygen species (ROS) accumulation. Current therapeutic approaches often lack synchronized antimicrobial-regenerative mechanisms and fail to provide sustained efficacy. Here, this work engineers a bioengineered living hydrogel system (BMB181@ALG) that leverages genetically modified Bacillus thuringiensis strain BMB181 as a melanin nanofactory, enabling in situ biosynthesis of multifunctional melanin nanoparticles (MNPs). Encapsulation within the hydrogel preserves bacterial metabolic activity, ensuring continuous MNPs production. These nanoparticles exhibit a dual-mode therapeutic action, including photothermal antibacterial activity under near-infrared irradiation for biofilm disruption and pathogen eradication, and ROS scavenging and antioxidant effects to modulate the inflammatory microenvironment. The sustained release of MNPs further promotes angiogenesis, enhances tissue regeneration, and dynamically regulates the diabetic wound microenvironment. Notably, the self-replenishing nature of this biohybrid system ensures long-term therapeutic efficacy, minimizing the need for frequent interventions. This study establishes a bacteria-driven therapeutic paradigm, demonstrating the translational potential of living microbial systems for next-generation precision wound management.
科研通智能强力驱动
Strongly Powered by AbleSci AI